Skip to main content

Table 2 Determination of vaginal insertion of applicators from participants returning sets 100% evaluable (n = 101)

From: Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial

Percent of applicators in the set deemed vaginally inserted

Number of participants (n)

Percent of total participants

0%

12

11.8%

1–79%

7

6.9%

80–100%

82

81.2%

Totals

101

100%